论文部分内容阅读
目的 :评价我院对新生儿黄疸早期干预的临床效果。方法 :早期干预 :本人血型“O”型、丈夫“A”或“B”型血、妊娠≥ 38周的孕妇口服苯巴比妥 30mg/次 ,每日三次 ,连服一周 ,辅以维生素C、E ;生后 7天内皮测≥ 18u(8mg/dl)的新生儿服中药“茵陈汤”或驱黄合剂 ,连续 3天 ;及皮测≥ 2 2u(12mg/dl)提前入新生儿科治疗。比较实施与未实施早期干预的逐年新生儿高胆发生率及严重程度。结果 :高胆发生率由 1994年的 13.6 %下降到 1995 - 1999年的 6 .8- 11.1% (x2 >7,88,P <0 .0 0 5 )、严重高胆发生率由 1994年的 1.5 4%下降到 1995 - 1999年的 0 .5 2 - 0 .78% (x2 >3.84,P <0 .0 5 )。结论 :我院对新生儿黄疸的早期干预能有效地降低新生儿高胆的发生率及严重程度。
Objective: To evaluate the clinical effect of early intervention in neonatal jaundice in our hospital. Methods: Early intervention: My blood type “O” type, husband “A” or “B” type blood, pregnant women ≥ 38 weeks of pregnancy phenobarbital 30mg / times, three times a day, and even served a week, supplemented with vitamin C , E; 7 days after birth, skin test ≥ 18u (8mg / dl) of newborn Chinese medicine “Yin Chen Tang” or Huanghuang mixture for 3 days; and skin test ≥ 22u (12mg / dl) into the neonatology treatment. Compare the annual neonatal hyperbilirubinemia and severity with and without early intervention. Results: The incidence of hypercholesterolemia decreased from 13.6% in 1994 to 6.8-11.1% (x2> 7,88, P <0.05) in 1995-1999. The incidence of severe hyperbilirubinemia increased from 13.6% in 1994 1.5 4% to 0.52 - 0.78% in 1995-1999 (x2> 3.84, P <0.05). Conclusion: Early intervention in neonatal jaundice in our hospital can effectively reduce the incidence and severity of neonatal hypercholesterolemia.